The AT(N) framework, introduced by the National Institute on Aging (NIA) and the Alzheimer's Association (AA), is recognized as a valuable system for classifying AD biomarkers10: A = Aβ, T = tau, and N = neurodegeneration.11 The gene discussed is MAPT; the disease is Alzheimer disease.